When did Xenon Pharmaceuticals report Q4 2024 earnings?

Xenon Pharmaceuticals (XENE) reported Q4 2024 earnings on February 27, 2025 after market close.

What were Xenon Pharmaceuticals's Q4 2024 revenue and EPS?

Xenon Pharmaceuticals reported revenue of - and eps of $-0.84 for Q4 2024.

Did Xenon Pharmaceuticals beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.89 by $0.05.

Where can I find Xenon Pharmaceuticals's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-029149) directly on SEC EDGAR. The filing index links above go to sec.gov.

Xenon Pharmaceuticals XENE Q4 2024 Annual earnings

Reported February 27, 2025 · After market close

Revenue-

EPS-$0.84Beat by $0.05

EPS estimate-$0.89

Next report

Aug 10, 2026 (In 1 week)

Revenue estimate$1.7M

EPS estimate-$1.16

Financials

Q4 2024

Income statement

See full

Revenue-—

Operating income-$77.5M-44.3%

Net income-$65.7M-46.8%

EPS (diluted)-$0.84-31.2%

Balance sheet

See full

Cash & equivalents$142.7M-4.0%

Total debt$9.0M-17.3%

Total equity$754.9M-18.6%

Total assets$798.1M-17.3%

Cash flow

See full

Operating cash flow-$54.4M-53.6%

CapEx$783.0K+904%

Free cash flow-$55.2M-55.5%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$2.99B-7.3%

Enterprise value$2.85B-7.5%

Returns & leverage

See full

Return on equity-27.8%+9.7pp

Debt / equity0×0.0×

Current ratio17.8×-5.8×

Versus estimates

Revenue

Q1 2025$7.5MBeat by $5.6M

Diluted EPS

Q1 2026-$1.17In line Q4 2025-$1.31Miss by $0.11 Q3 2025-$1.15Beat by $0.01 Q2 2025-$1.07Miss by $0.04 Q1 2025-$0.83Beat by $0.11

Q4 2024-$0.84Beat by $0.05

Ask the moment Xenon Pharmaceuticals reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Xenon Pharmaceuticals report Q4 2024 earnings?: Xenon Pharmaceuticals (XENE) reported Q4 2024 earnings on February 27, 2025 after market close.
What were Xenon Pharmaceuticals's Q4 2024 revenue and EPS?: Xenon Pharmaceuticals reported revenue of - and eps of $-0.84 for Q4 2024.
Did Xenon Pharmaceuticals beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.89 by $0.05.
Where can I find Xenon Pharmaceuticals's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-029149) directly on SEC EDGAR. The filing index links above go to sec.gov.